LBPH Longboard Earnings per share growth rate in current year

Official company branding of longboardpharma.com (LBPH)

The battle for patents in the field of rare nervous system pathologies creates serious risks, as visualized by the year-over-year EPS trend for Longboard Pharmaceuticals (LBPH). The 8.60 metric reflects current dynamics, confirming an R&D stage with fixed costs. However, FDA approval will ensure high margins through outsourcing, while the influx of capital into the anti-epileptic segment will accelerate the commercial launch.

Longboard Pharmaceuticals Inc (LBPH) Earnings per share growth in current year: for the period 07/04/2022 - 12/07/2024

Comprehensive metric breakdowns and analytics for Longboard Pharmaceuticals, Inc. (LBPH)

- share price and consensus valuation forecast:
Basic company analysis:Longboard Pharma LBPH
Brand item of longboardpharma.com

This indicator reflects the year-over-year growth rate of earnings per share, allowing for an assessment of the actual speed of business scaling. By analyzing the EPS growth dynamics compared to last year, an investor determines the efficiency of profit generation relative to previous periods. For Longboard Pharmaceuticals (LBPH), this metric confirms financial stability amid high confidence in management, which is successfully preparing the commercial launch of its epilepsy drug.

Direct competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|ATHA (Athira) - Earnings per share increase in current year|Addex Therapeutics - Net earnings per share growth this year|ALZN - Net earnings per share growth this year|Cyclerion Therapeutics, Inc. - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Net earnings per share growth this year|Earnings per share growth this year CRGT|Net earnings per share growth this year ATXI|Net earnings per share growth this year Brainstorm Cell (BCLI)|Net earnings per share growth this year CARA (Cara Therapeutics, Inc.)|Net earnings per share growth this year Chromocell Therapeutics Corp CHRO|Earnings growth in current year ELYM (Eliem Therapeutics, Inc.)|Earnings growth in current year intracellulartherapies.com ITCI|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE